NHS to Offer Improved Stop Smoking Pill in England

Nov.15.2024
NHS to Offer Improved Stop Smoking Pill in England
NHS will start offering an "improved" stop smoking pill to tens of thousands of people in England who want to quit cigarettes.

According to a recent report by the BBC, the National Health Service (NHS) in the UK will begin offering an "improved" stop smoking pill to tens of thousands of people in England who are looking to quit smoking.

 

The NHS has stated that Varenicline is as effective as e-cigarettes and more effective than nicotine replacement gum or patches.

 

This medication can suppress nicotine addiction and was previously marketed under the brand name Champix on the NHS several years ago. However, it was withdrawn due to some impurity issues. The new version has now been approved as safe.

 

Officials stated that e-cigarettes are sometimes provided, typically by local NHS stop smoking services, with an initial e-cigarette starter kit provided for approximately two weeks.

 

Varenicline is a prescription medication, which means people cannot purchase it over the counter at a pharmacy or supermarket and instead need to see their general practitioner (GP) or NHS stop smoking service to obtain it. It works by reducing cravings for nicotine and blocking its effects on the brain, while also helping to alleviate withdrawal symptoms such as irritability or difficulty sleeping.

 

The NHS states that it has been proven to help approximately one quarter of people quit smoking for at least six months when used in conjunction with behavioral support, such as counseling. The study suggests that this could help over 85,000 people quit smoking each year and potentially prevent around 9,500 smoking-related deaths in the next five years.

 

Health and Social Care Secretary Wes Streeting said: "The rollout of this pill can save the NHS millions of pounds, save appointments to help other patients be seen faster and save lives."

 

NHS CEO Amanda Pritchard announced at the annual NHS Providers conference that this drug could be a "game-changer" for those looking to quit smoking.

 

Due to e-cigarettes not being licensed as medication, general practitioners are unable to prescribe e-cigarettes for individuals attempting to quit smoking unless approved by the local NHS. However, some local governments do indeed provide e-cigarettes for smokers wanting to quit.

 

The guidelines suggest that people first try to obtain licensed smoking cessation medications, even though e-cigarettes are recognized as a smoking cessation aid. The harms of e-cigarettes are far less than smoking.

 

However, health experts unanimously agree that people should not start using e-cigarettes unless it is for smoking cessation.

 

Hazel Cheeseman, chief executive of Action on Smoking and Health, said access to services was variable.

 

"Wherever a smoker lives, they should be able to access the most effective forms of treatment to help them stop," she said.

 

"Improving access to varenicline will be a positive step forward to help prevent the tens of thousands of deaths caused by smoking. However, a drug alone will not transform smoking rates. Services are needed to support smokers and prescribe these products."

 

"The NHS has done a good job in setting up in-hospital support to help people quit smoking, which complements the services provided in the community, said Hazel Cheeseman. "But gaps remain around the country, with services often in peril as local NHS organizations try to balance the books."

 

China Tobacco Hubei Industrial Patent Discloses Nicotine Tooth Patch for Fixed Oral Delivery
China Tobacco Hubei Industrial Patent Discloses Nicotine Tooth Patch for Fixed Oral Delivery
According to Chinese patent records, a “nicotine tooth patch” application filed by China Tobacco Hubei Industrial Corporation (CTHB) and Hubei Xinye Tobacco Sheet Development Co., Ltd. was published on May 19, 2026. The filing proposes a nicotine gel patch that adheres to the tooth surface, especially the lingual side, to reduce displacement, foreign-body sensation, and accidental swallowing risks associated with existing oral nicotine products.
Jun.10
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15
Data|China’s January-May Vape Exports: U.S. Shipments Fall 13.8% as Japan Posts Fastest Growth
Data|China’s January-May Vape Exports: U.S. Shipments Fall 13.8% as Japan Posts Fastest Growth
According to China Customs export data analyzed by 2Firsts, the United States remained China’s largest destination for vape-related exports during January-May 2026 despite a 13.82% year-on-year decline in export value. Meanwhile, exports to Japan, Russia, Indonesia and the United Arab Emirates recorded strong growth, highlighting continued diversification across China’s export markets.
Special Report
Jun.29
Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%
Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%
Data from convenience insight agency Talysis shows that the value of tobacco, vapes and smoking alternatives in the independent convenience sector fell by 4.4% in the first quarter of 2026, while volume fell by 7.8%. The vaping subcategory declined by 3.9% in value and 10.3% in volume over the same period. Talysis said the impact of the disposable vape ban continues to pressure turnover and footfall.
May.08 by 2FIRSTS.ai
InterTabac 2026: First conference program highlights now available online
InterTabac 2026: First conference program highlights now available online
With three months to go before the international tobacco and nicotine industry gathers again in Dortmund, InterTabac, together with NUBIZ and InterSupply, is set to bring around 800 exhibitors from across the globe to eleven exhibition halls. The three events will showcase innovation, market trends and industry networking, while the first conference program highlights are now online, offering trade visitors keynotes, panel discussions and masterclasses to support business decision-making.
Events
Jun.22
Argentina Issues Resolution 549/2026 to Regulate Vapes, Heated Tobacco and Nicotine Pouches
Argentina Issues Resolution 549/2026 to Regulate Vapes, Heated Tobacco and Nicotine Pouches
Argentina’s government has created a comprehensive regulatory framework for nicotine products, including vapes, heated tobacco and nicotine pouches, through Resolution 549/2026 published in the Official Gazette. The new regulation ends the previous prohibitive framework and establishes rules to organize the market by requiring traceability, quality standards and mandatory registration for all manufacturers and retailers operating in the country.
May.06 by 2FIRSTS.ai